Avanos Medical Inc
AVNS11.410USD
+0.010+0.09%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
529.62MMarket Cap
LossP/E TTM
More Details of Avanos Medical Inc Company
Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
Avanos Medical Inc Info
Ticker SymbolAVNS
Company nameAvanos Medical Inc
IPO dateOct 21, 2014
CEOPacitti (David)
Number of employees2227
Security typeOrdinary Share
Fiscal year-endOct 21
Address5405 Windward Parkway
CityALPHARETTA
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code30004
Phone18444282667
Websitehttps://avanos.com/
Ticker SymbolAVNS
IPO dateOct 21, 2014
CEOPacitti (David)
Company Executives of Avanos Medical Inc
Name
Name/Position
Position
Shareholding
Change
Mr. David Pacitti
Mr. David Pacitti
Chief Executive Officer, Director
Chief Executive Officer, Director
242.05K
--
Mr. Gary D. Blackford
Mr. Gary D. Blackford
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
91.59K
+27.94%
Mr. Patrick J. O'Leary
Mr. Patrick J. O'Leary
Independent Director
Independent Director
66.64K
--
Dr. Julie Ann Shimer, Ph.D.
Dr. Julie Ann Shimer, Ph.D.
Independent Director
Independent Director
62.09K
--
Mr. Sigfrido (Sig) Delgado
Mr. Sigfrido (Sig) Delgado
Senior Vice President - Integrated Supply Chain
Senior Vice President - Integrated Supply Chain
44.12K
+58.59%
Mr. Jason M. Pickett
Mr. Jason M. Pickett
Vice President - Corporate Finance, Treasurer
Vice President - Corporate Finance, Treasurer
--
--
Ms. Indrani L. Franchini, J.D.
Ms. Indrani L. Franchini, J.D.
Independent Director
Independent Director
--
--
Mr. Scott Galovan
Mr. Scott Galovan
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Dr. Lisa C. Egbuonu-Davis, M.D.
Dr. Lisa C. Egbuonu-Davis, M.D.
Independent Director
Independent Director
--
--
Ms. Camille Chang Gilmore
Ms. Camille Chang Gilmore
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. David Pacitti
Mr. David Pacitti
Chief Executive Officer, Director
Chief Executive Officer, Director
242.05K
--
Mr. Gary D. Blackford
Mr. Gary D. Blackford
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
91.59K
+27.94%
Mr. Patrick J. O'Leary
Mr. Patrick J. O'Leary
Independent Director
Independent Director
66.64K
--
Dr. Julie Ann Shimer, Ph.D.
Dr. Julie Ann Shimer, Ph.D.
Independent Director
Independent Director
62.09K
--
Mr. Sigfrido (Sig) Delgado
Mr. Sigfrido (Sig) Delgado
Senior Vice President - Integrated Supply Chain
Senior Vice President - Integrated Supply Chain
44.12K
+58.59%
Mr. Jason M. Pickett
Mr. Jason M. Pickett
Vice President - Corporate Finance, Treasurer
Vice President - Corporate Finance, Treasurer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Digestive Health
102.70M
62.74%
Pain Management
61.00M
37.26%
By RegionUSD
Name
Revenue
Proportion
North America
138.50M
84.61%
Europe, Middle East and Africa
22.80M
13.93%
Asia Pacific and Latin America
13.70M
8.37%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Digestive Health
102.70M
62.74%
Pain Management
61.00M
37.26%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.24%
T. Rowe Price Investment Management, Inc.
10.15%
The Vanguard Group, Inc.
7.24%
Armistice Capital LLC
5.39%
Dimensional Fund Advisors, L.P.
5.07%
Other
58.91%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.24%
T. Rowe Price Investment Management, Inc.
10.15%
The Vanguard Group, Inc.
7.24%
Armistice Capital LLC
5.39%
Dimensional Fund Advisors, L.P.
5.07%
Other
58.91%
Shareholder Types
Shareholders
Proportion
Investment Advisor
48.44%
Investment Advisor/Hedge Fund
27.84%
Hedge Fund
16.02%
Individual Investor
4.09%
Research Firm
2.80%
Family Office
1.97%
Pension Fund
1.24%
Bank and Trust
0.47%
Sovereign Wealth Fund
0.05%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
599
44.88M
113.89%
+5.76K
2025Q3
617
45.01M
114.39%
-81.05K
2025Q2
610
45.14M
115.30%
+1.07M
2025Q1
615
44.04M
105.94%
-4.70M
2024Q4
596
44.47M
105.92%
+325.84K
2024Q3
583
44.12M
104.92%
+568.23K
2024Q2
585
43.69M
107.04%
-931.37K
2024Q1
593
44.72M
107.68%
-5.03M
2023Q4
601
45.14M
107.42%
+359.77K
2023Q3
598
44.92M
104.35%
-994.38K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
6.23M
13.43%
-169.53K
-2.65%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
4.00M
8.61%
+238.94K
+6.36%
Jun 30, 2025
The Vanguard Group, Inc.
4.40M
9.49%
-883.40K
-16.71%
Jun 30, 2025
Armistice Capital LLC
2.04M
4.39%
+36.00K
+1.80%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.58M
5.56%
-17.29K
-0.67%
Jun 30, 2025
Brown Advisory
1.81M
3.9%
-122.33K
-6.33%
Jun 30, 2025
State Street Investment Management (US)
1.92M
4.13%
-11.80K
-0.61%
Jun 30, 2025
D. E. Shaw & Co., L.P.
1.19M
2.57%
+102.95K
+9.45%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.07M
2.31%
-2.50K
-0.23%
Jun 30, 2025
AQR Capital Management, LLC
560.05K
1.21%
+367.19K
+190.39%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
0.8%
Invesco S&P SmallCap 600 Pure Value ETF
0.43%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.37%
Invesco S&P SmallCap Health Care ETF
0.32%
Royce Quant Small-Cap Quality Value ETF
0.31%
Harbor Human Capital Factor US Small Cap ETF
0.22%
Vanguard US Value Factor ETF
0.15%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.13%
Fidelity Enhanced Small Cap ETF
0.13%
Pacer US Small Cap Cash Cows ETF
0.09%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion0.8%
Invesco S&P SmallCap 600 Pure Value ETF
Proportion0.43%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proportion0.37%
Invesco S&P SmallCap Health Care ETF
Proportion0.32%
Royce Quant Small-Cap Quality Value ETF
Proportion0.31%
Harbor Human Capital Factor US Small Cap ETF
Proportion0.22%
Vanguard US Value Factor ETF
Proportion0.15%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proportion0.13%
Fidelity Enhanced Small Cap ETF
Proportion0.13%
Pacer US Small Cap Cash Cows ETF
Proportion0.09%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Avanos Medical Inc?
The top five shareholders of Avanos Medical Inc are:
BlackRock Institutional Trust Company, N.A. holds 6.23M shares, accounting for 13.43% of the total shares.
T. Rowe Price Investment Management, Inc. holds 4.00M shares, accounting for 8.61% of the total shares.
The Vanguard Group, Inc. holds 4.40M shares, accounting for 9.49% of the total shares.
Armistice Capital LLC holds 2.04M shares, accounting for 4.39% of the total shares.
Dimensional Fund Advisors, L.P. holds 2.58M shares, accounting for 5.56% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 6.23M shares, accounting for 13.43% of the total shares.
T. Rowe Price Investment Management, Inc. holds 4.00M shares, accounting for 8.61% of the total shares.
The Vanguard Group, Inc. holds 4.40M shares, accounting for 9.49% of the total shares.
Armistice Capital LLC holds 2.04M shares, accounting for 4.39% of the total shares.
Dimensional Fund Advisors, L.P. holds 2.58M shares, accounting for 5.56% of the total shares.
What are the top three shareholder types of Avanos Medical Inc?
The top three shareholder types of Avanos Medical Inc are:
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
How many institutions hold shares of Avanos Medical Inc (AVNS)?
As of 2025Q4, 599 institutions hold shares of Avanos Medical Inc, with a combined market value of approximately 44.88M, accounting for 113.89% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.51%.
What is the biggest source of revenue for Avanos Medical Inc?
In FY2025Q2, the Digestive Health business generated the highest revenue for Avanos Medical Inc, amounting to 102.70M and accounting for 62.74% of total revenue.
